Filing Details

Accession Number:
0001171843-14-000871
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-21 15:57:56
Reporting Period:
2014-02-18
Filing Date:
2014-02-21
Accepted Time:
2014-02-21 15:57:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1365216 Sucampo Pharmaceuticals Inc. SCMP Pharmaceutical Preparations (2834) 133929237
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1383377 R Gayle Dolecek 4520 East West Hwy, 3Rd Floor
Bethesda MD 20814
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2014-02-18 9,067 $4.41 9,067 No 4 M Direct
Class A Common Stock Disposition 2014-02-18 9,067 $8.04 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2014-02-18 9,067 $0.00 9,067 $4.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
314,567 2013-05-02 2021-05-02 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on June 13, 2013
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.14, inclusive. The reporting person undertakes to provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.